Updated Jul 16, 2026
Furuta Milano has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Furuta Milano is the Chief Financial Officer at Takeda Pharmaceutical Company Limited, a global biopharmaceutical company headquartered in Japan. As CFO, Milano is responsible for overseeing the financial operations and strategy of the company, contributing to its growth and stability in the pharmaceutical industry.
| Role | Chief Financial Officer, Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 12.3K | $0.00 | |
| 2026-04-28 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 7.8K | $0.00 |
Furuta Milano is the Chief Financial Officer at Takeda Pharmaceutical Company Limited, a global biopharmaceutical company headquartered in Japan. As CFO, Milano is responsible for overseeing the financial operations and strategy of the company, contributing to its growth and stability in the pharmaceutical industry.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Furuta Milano profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.